BEHRENS M KATHLEEN bought SRPT
March 1, 2024 · Form 4 insider transaction
BEHRENS M KATHLEEN bought 3,679 shares of Sarepta Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,679
Price
$0.00
Total value
N/A
InsiderBEHRENS M KATHLEEN
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 1, 2024
Filing dateMarch 5, 2024
Shares owned after3,679
OwnershipDirect
10b5-1 planNo
AmendedNo